M&A Deal Summary |
|
---|---|
Date | 2021-03-31 |
Target | Amoun Pharmaceutical Company |
Sector | Medical Products |
Buyer(s) | ADQ |
Sellers(s) | Bausch Health |
Deal Type | Divestiture |
Deal Value | 740M USD |
SEARCH BY
Try For Free 7-Day Free Trial
ADQ is a holding company with direct and indirect investments with portfolio of key sectors across Abu Dhabi's economy, including food and agriculture, aviation, financial services, healthcare, industries, logistics, media, real estate, tourism and hospitality, transport and utilities. ADQ was founded in 2018 and is based in Abu Dhabi, UAE.
DEAL STATS | # |
---|---|
Overall | 2 of 4 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (Egypt) | 1 of 1 |
Year (2021) | 1 of 2 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-05-06 |
Al Nabil Food
Amman, Jordan Al Nabil Food produces over 200 frozen and chilled food products including beef and chicken burgers, chicken strips and nuggets, cold cuts, ethnic foods, pre-cooked meals, and sweets. Al Nabil Food was founded in 1945 and is based in Amman, Jordan. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-09-16 |
Acino
Zurich, Czech Republic Acino is a pharmaceutical company focused on developing, manufacturing and marketing well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino was founded in 1836 and is based in Zurich, Czech Republic. |
Buy | - |
Category | Company |
---|---|
Sector | Life Science |
Employees | 20,270 |
Revenue | 8.8B USD (2023) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
DEAL STATS | # |
---|---|
Overall | 10 of 10 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 10 of 10 |
Country (Egypt) | 1 of 1 |
Year (2021) | 1 of 1 |
Size (of disclosed) | 3 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-09-21 |
Allegro Ophthalmics - Ophthalmology Assets
San Juan Capistrano, California, United States Allegro Ophthalmics LLC - Ophthalmology Assets includes global rights for risuteganib (Luminate®)1, Allegro's lead investigational compound in the retina, which is believed to simultaneously act on the angiogenic, inflammatory, and mitochondrial metabolic pathways implicated in diseases such as intermediate dry Age-related Macular Degeneration (AMD). |
Buy | - |